The goal of this study was to compare the feasibility and safety of robotic-assisted (RA) transradial (TR) carotid artery stenting (CAS) with manual TR CAS using the CorPath GRX.
The researchers used a retrospective study of a prospectively maintained database to find 13 patients who had TR CAS between June 2019 and February 2020. The patients were separated into two groups. Technical success was accomplished in all 6 (100%) surgeries in the RA group, with a mean age of 70.0 years. There were no technical or access-site difficulties, and no catheter swaps. A convoluted aortic arch necessitated transfemoral conversion in one (16.7 percent) case. Myocardial infarction, stroke, or mortality were not reported as perioperative problems.
The average procedure time in the RA group was substantially longer than in the control group (61.2 17.5 minutes vs 85.0 14.3 minutes [95 percent CI 69.9–100.0]). There was no statistically significant difference in baseline characteristics, fluoroscopy time, contrast dose, radiation exposure, catheter exchanges, technical success, transfemoral conversion, technical or access-site complications, myocardial infarction, or technical or access-site complications. According to the authors’ findings, RA TR CAS is possible, safe, and effective. Prior to comprehensive remote control, neurovascular-specific technical and software adjustments are required. Patients’ access to lifesaving procedures for illnesses like stroke and aneurysm rupture, as well as operative precision, are both impacted by remote control. Clinical trials involving lars will be conducted in the future.
Reference Link – https://thejns.org/view/journals/j-neurosurg/135/1/article-p21.xml
